Yuanta Investment

Yuanta Investment is a venture capital investment firm established in 1989 and headquartered in Seoul, South Korea. The company focuses on identifying and nurturing potential growth opportunities within various sectors, primarily through private equity investments. By leveraging its expertise and resources, Yuanta Investment aims to enhance the development of emerging companies, facilitating their ascension in the market. The firm is dedicated to fostering innovation and supporting entrepreneurs in their endeavors, contributing to the overall growth of the economy in the region.

Mook Choi

Senior Manager, Venture Capital

Matthew Choi

Managing Director

SangWoon Hwang

CEO

David Jang

Manager, Venture Capital

Vincent Jeong

Managing Director and Head of Venture Capital

Byungwoo Kim

Managing Director, Private Equity

Sang-Woo Park

Managing Director

Steve Park

Managing Director

JoonSang Yoo

Managing Director

44 past transactions

Selta Square

Series A in 2025
Selta Square is an AI-driven company specializing in drug monitoring solutions. It has developed an intelligent pharmacovigilance platform that aims to enhance the drug safety monitoring process by leveraging advanced artificial intelligence and digital technologies. The platform supports pharmacovigilance experts by automating routine tasks, thereby allowing them to concentrate on critical functions such as adverse case management and medical evaluation of medications. Through these innovative services, Selta Square seeks to improve the efficiency and effectiveness of pharmacovigilance practices in the healthcare industry.

Pin Therapeutics

Series C in 2024
Pin Therapeutics, Inc. is a biotechnology company founded in February 2017 and headquartered in South San Francisco, California. The company is focused on developing therapeutic products that harness protein degradation technology to target immune diseases, cancer, and aging-related conditions. Pin Therapeutics employs advanced screening systems, including its PinE3 platform for E3 ligase identification and the PinGLUE system for molecular glue degrader discovery. With a diverse team comprising experienced professionals from global pharmaceutical and biotech sectors, the company is actively advancing several programs, including selective molecular glue degraders and a PROTAC program. Through its innovative approaches to drug discovery, Pin Therapeutics aims to address critical unmet medical needs while enhancing the efficiency and specificity of protein degradation in therapeutic contexts.

Mepsgen

Series C in 2024
Mepsgen is a biotechnology research organization that focuses on pharmaceutical services and drug development.

Panmnesia

Series A in 2024
Panmnesia is a Korean startup specializing in the development of advanced chip technology. The company is dedicated to creating intellectual property surrounding a technology known as Compute Express Link, which facilitates the pooling of various devices, including AI accelerator chips, processors, and memory, for large data center operators. By enhancing the interoperability of these systems, Panmnesia aims to enable companies to efficiently harness and integrate a diverse array of system components, optimizing performance and resource utilization in high-capacity computing environments.

RideFlux

Series B in 2024
RideFlux Inc. is a South Korean company that specializes in developing self-driving technology for automobiles. Founded in 2018 and headquartered on Jeju Island, the company aims to create safe and reliable autonomous transportation services. Jeju Island offers a diverse range of road environments and weather conditions, making it an ideal location for testing and enhancing autonomous driving software. RideFlux focuses on providing innovative solutions that improve the driving experience, emphasizing safety and efficiency in transportation. The company's offerings include autonomous driving software, remote control services, and high-precision mapping solutions, all designed to meet the growing demand for mobility services in urban environments. Through its advancements in self-driving technology, RideFlux aspires to contribute to a future where transportation is safer and more comfortable for everyone.

Inventera Pharmaceuticals

Series C in 2024
Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.

Rznomics

Venture Round in 2024
Rznomics is a biotechnology company founded by Professor Lee Sung-wook's lab, specializing in the development of ribonucleic acid-based gene therapies. The company focuses on creating innovative biopharmaceuticals aimed at addressing significant medical challenges, particularly in the treatment of liver cancer, various cancers, degenerative neurological diseases, and hereditary disorders. Rznomics has been recognized for its technological advancements and was selected by the TIPS program, highlighting its commitment to addressing medical needs that remain unmet in current healthcare. Through its research and development efforts, Rznomics aims to enable medical practitioners to effectively treat complex conditions such as cancer and Alzheimer's disease.

FASSTO

Series D in 2024
FASSTO is a consulting company that specializes in providing fulfillment services for online merchants, focusing on their packaging, delivery, logistics, and shipping needs. By leveraging digital technologies such as artificial intelligence and big data, FASSTO aims to create a user-friendly environment for businesses with limited resources, including one-person operations and those shipping single items. This approach enables clients to save time and money, allowing them to concentrate on other critical aspects of their enterprises.

ADEL

Series B in 2024
The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective of developing therapeutic and diagnostic agents for neurological diseases, particularly Alzheimer's disease. In 2016, the company took significant steps toward formalizing its presence in the market by completing its incorporation and business registration processes. The year 2017 proved to be a milestone for the company as it obtained certification as a corporate-affiliated research institute, solidifying its position as a reputable research-driven organization. Additionally, it garnered recognition as a leading university start-up by the Ministry of SMEs and Startups, further boosting its credibility and potential for growth. The company has collaborated with Oscotech Co., Ltd. and partnered with various investors, including Kite Entrepreneurship Foundation, Stone Bridge Ventures Co., Ltd., Korea Development Bank, and Stick Ventures Co., Ltd., to jointly develop their projects.

Panmnesia

Seed Round in 2023
Panmnesia is a Korean startup specializing in the development of advanced chip technology. The company is dedicated to creating intellectual property surrounding a technology known as Compute Express Link, which facilitates the pooling of various devices, including AI accelerator chips, processors, and memory, for large data center operators. By enhancing the interoperability of these systems, Panmnesia aims to enable companies to efficiently harness and integrate a diverse array of system components, optimizing performance and resource utilization in high-capacity computing environments.

K-NETZ

Series A in 2023
K-NETZ is an IT company that provides value-oriented R&D and possesses global technological competitiveness services.

Nexel

Venture Round in 2023
Nexel is a biotechnology research firm focused on advancing drug discovery and biotherapeutics. The company specializes in developing high-quality induced pluripotent stem cell (iPSC) products using embryonic stem cell technology. By providing innovative solutions and drug discovery pipelines, Nexel aims to address unmet medical needs and enhance therapeutic options for various diseases.

Eloi MateriaLs

Seed Round in 2023
Eloi MateriaLs is a materials technology firm that focuses on advanced alloys, metal powders, PVD coatings, and metal 3D printing.

THE PIRATES

Series C in 2022
The Pirates Co., Ltd. specializes in the development and operation of a mobile application that serves both wholesale and retail markets for seafood products. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an aquatic market news platform that delivers information on fresh seafood offerings. This platform connects consumers with suppliers, providing essential insights into the quality of marine products and facilitating informed purchasing decisions. Through its innovative approach, The Pirates aims to enhance the seafood purchasing experience by bridging the gap between consumers and the fish market.

Cureverse

Series A in 2022
Cureverse operates a pharmaceutical research and development company for the treatment of encephalopathy and oncology diseases. The company focuses on creating remedies for challenging brain conditions like dementia, thereby assisting healthcare professionals in enhancing human well-being and overall quality of life.

Neonesia

Series B in 2022
NeoNesia is a marketplace and software-as-a-service (SaaS) company based in Indonesia, focused on empowering small and medium enterprises (SMEs). It operates a business-to-business e-commerce platform that facilitates the buying and selling of prepaid top-ups. The platform features a prepaid charging distribution system combined with a digital payment portal, allowing customers to purchase digital products online. By streamlining the transaction process for SMEs, NeoNesia enhances their ability to engage in the digital economy and expand their product offerings.

Cellico

Seed Round in 2022
Cellico is a medical device company focused on creating innovative solutions for vision loss. The company specializes in the development of electronic eyeglasses, which incorporate augmented reality technology and microelectronics to assist visually impaired individuals. By leveraging advanced technology, Cellico aims to enhance human health and improve the quality of life for those with visual impairments through its innovative healthcare products.

FASSTO

Series C in 2022
FASSTO is a consulting company that specializes in providing fulfillment services for online merchants, focusing on their packaging, delivery, logistics, and shipping needs. By leveraging digital technologies such as artificial intelligence and big data, FASSTO aims to create a user-friendly environment for businesses with limited resources, including one-person operations and those shipping single items. This approach enables clients to save time and money, allowing them to concentrate on other critical aspects of their enterprises.

iN Therapeutics

Series B in 2022
iN Therapeutics is a biotechnology company focused on developing novel therapies for patients with intractable neurological disorders. Its drug development platform concentrates on Nav1.7 non-narcotic analgesics, hearing loss treatments, and brain disease therapeutics, aiming to provide pharmaceutical and biotech industries access to innovative central nervous system disease drugs.

Kukka

Series B in 2022
Kukka, Inc. is a Seoul-based company that specializes in providing a variety of flower-related services, including flower subscription, bouquet delivery, and custom floral design. Established in 2014, Kukka aims to promote the enjoyment of flowers in everyday life, inspired by Finnish culture. Its offerings cater to both individual and corporate clients, featuring corporate event support flowers, promotional flower boxes, and floral decorations. The company also provides same-day delivery and organizes flower art classes, enhancing the floral experience for its customers. Through its retail stores and online platform, Kukka facilitates easy access to fresh flowers and related accessories.

i.M

Series A in 2022
i.M is a lifestyle mobility service that offers online platform and app for cab rides and vehicle rentals.

Dealicious

Series C in 2022
Dealicious operates as an online marketplace designed to connect fashion wholesalers and retailers on a global scale. By facilitating direct access to a vast selection of quality merchandise, including clothing, bags, shoes, and accessories, Dealicious streamlines the wholesale purchasing process. The platform primarily focuses on the Dongdaemun fashion district in South Korea, renowned for its concentration of fashion manufacturing and distribution within a compact area. With approximately 11,000 registered wholesale stores, Dealicious enables retailers to browse and order from a diverse array of items, with 24,000 new products added daily. This approach eliminates the need for retailers to visit physical markets, allowing them to save valuable time and resources. Dealicious is committed to enhancing the user experience by continuously developing customer-centric services that ensure seamless access to high-quality products in the Korean fashion market.

Yeoshin

Series B in 2021
Yeoshin is a skin treatment information platform.

AMCG

Series A in 2021
AMCG is a developer of medical diagnostic devices focused on detecting cardiac-related conditions. The company utilizes applied computer science, artificial intelligence, and big data to enhance the capabilities of its diagnostic tools. AMCG's diagnostic imaging platform supports healthcare professionals in accurately diagnosing medical conditions and heart diseases, thereby contributing to improved patient care and outcomes. Through its innovative approach, AMCG aims to advance the field of medical diagnostics with cutting-edge technology.

Kasa

Venture Round in 2021
Kasa Korea Co., Ltd. is a company based in Seoul, South Korea, that specializes in developing a digital securities blockchain platform tailored for the real estate market. Established in 2018, Kasa's platform enables users to buy and trade securitized commercial real estate assets as asset-backed securities. By leveraging blockchain technology, the company aims to provide retail investors with a transparent and streamlined process for investing in real estate, facilitating the buying and selling of securitized assets in a more efficient manner.

Tiki

Series E in 2021
Tiki is an e-commerce company that operates a comprehensive platform offering a diverse array of products across multiple categories, including electric appliances, fashion accessories, mobile devices, and health products. With a catalog of over 300,000 items, Tiki partners with various global brands to enhance its product offerings. The company emphasizes customer satisfaction through efficient logistics and reliable customer service, creating a secure and convenient shopping experience that allows customers to explore and purchase a wide variety of products from a single, user-friendly platform.

iN Therapeutics

Series A in 2021
iN Therapeutics is a biotechnology company focused on developing novel therapies for patients with intractable neurological disorders. Its drug development platform concentrates on Nav1.7 non-narcotic analgesics, hearing loss treatments, and brain disease therapeutics, aiming to provide pharmaceutical and biotech industries access to innovative central nervous system disease drugs.

Perfect Storm

Series A in 2021
Perfect Storm is a digital content and marketing solutions company based in Korea. It specializes in providing social media marketing services, leveraging innovative technologies to enhance advertising. By implementing augmented reality and virtual reality effects, Perfect Storm enables consumers to engage with brand products and services in an interactive and enjoyable manner. This approach not only enriches the consumer experience but also helps businesses increase their revenue by effectively showcasing their offerings in a dynamic way.

Gbike

Series B in 2021
Gbike is a mobility sharing startup in Korea, innovating green urban mobility in Korea where currently car-centric environment. Our service includes bike and scooter sharing with IT services specialized for Korean market & Asia, Pacifics.

3billion

Series C in 2021
3billion, Inc. is a genetic testing company based in Seoul, South Korea, founded in 2016. The company focuses on providing comprehensive genetic testing and analysis services specifically for patients with rare diseases. By leveraging bioinformatics and machine learning technologies, 3billion has significantly reduced both the time and costs associated with genome interpretation. Its artificial intelligence-driven diagnostic testing covers a wide range of genes and diseases, facilitating fast and accurate diagnoses. This innovative approach enables healthcare providers to more effectively identify genetic conditions, ultimately improving health outcomes for patients.

SolarConnect

Series C in 2021
SolarConnect, Inc. is a South Korean company that specializes in the production of solar energy and provides information technology-based energy solutions. Established in 2016 and headquartered in Seoul, the company operates solar energy plants and installs solar panels in residential areas and apartments. SolarConnect aims to integrate innovative financial and technological solutions into the solar and energy industries, contributing to the advancement of sustainable energy practices.

N.CODE

Series B in 2021
D.Code operates an e-commerce platform that connects customers directly with European luxury boutiques, offering a diverse selection of over 700 luxury brands and 100,000 items. The platform provides accurate product information, detailed descriptions, and competitive pricing, typically around 20% lower than retail prices in Korea. In addition to its curated shopping experience, D.Code offers personalized concierge services to enhance customer satisfaction. The company utilizes customer data to develop a fashion trend algorithm, enabling better purchasing decisions and assisting sellers with product sourcing and marketing strategies. By collaborating directly with luxury boutiques, D.Code ensures high-quality service and reasonable pricing, creating an efficient marketplace for luxury goods.

Shaperon

Series C in 2020
Shaperon Inc. is a South Korean biotechnology company established in 2008, specializing in the research and development of immunological cells and innovative therapeutics. The company focuses on creating inflammasome inhibitors and nanobody therapeutics designed to address various chronic inflammatory diseases, such as atopic dermatitis, systemic inflammatory response syndrome, and neuroinflammatory disorders. Shaperon offers a range of drug candidates, including a gel-type formulation for treating atopic dermatitis and other inflammatory conditions. By developing immunotherapeutic products and single-domain neutralizing antibodies, Shaperon aims to enhance patient quality of life through effective treatment options for chronic inflammation and related health issues.

Lmito Therapeutics

Series A in 2020
Lmito Therapeutics Inc. is a clinical-stage biotechnology company based in Seongnam-si, South Korea, founded in 2017. The company focuses on modulating cell metabolism to create innovative immunotherapeutic compounds in the fields of immunology, neuro-immunology, and immuno-oncology. Lmito specializes in the discovery of mitochondrial drugs aimed at addressing metabolic syndromes, age-related neurodegenerative diseases, and mitochondrial respiratory chain disorders. It develops treatments that regulate the metabolism of brain immune cells and targets auto-inflammatory and autoimmune diseases. Through its research and development efforts, Lmito Therapeutics aims to provide effective therapies for various neurological and immune-related disorders.

Cardoc

Private Equity Round in 2020
Cardoc Inc. is a South Korean company founded in 2013 that specializes in automotive repair services through a mobile application. The app allows users to upload photographs of their vehicle's exterior damage, facilitating real-time quotations, consultations, and repair options from selected car body shops. Users can receive their first estimate within an average of seven minutes and compare multiple estimates without the need to register personal information. Cardoc has demonstrated significant growth, with registered stores experiencing monthly increases of 30-100%. The company also offers additional vehicle management services, including car inspections, washes, and renewal services, which can be reserved online or at car centers. The founding team comprises automotive enthusiasts who have benefited from support from a startup incubation organization.

THE PIRATES

Series B in 2020
The Pirates Co., Ltd. specializes in the development and operation of a mobile application that serves both wholesale and retail markets for seafood products. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an aquatic market news platform that delivers information on fresh seafood offerings. This platform connects consumers with suppliers, providing essential insights into the quality of marine products and facilitating informed purchasing decisions. Through its innovative approach, The Pirates aims to enhance the seafood purchasing experience by bridging the gap between consumers and the fish market.

First Canvas

Series A in 2020
First Canvas is a media company focused on addressing diverse marketing challenges for businesses. It offers a range of services including content creation, distribution via platforms like Facebook pages, performance-based advertisements, and influencer marketing. These services are designed to help businesses launch efficient advertising campaigns quickly and achieve impactful results.

ZigBang

Venture Round in 2019
ZigBang Co., Ltd. is a property listing platform and application based in Seoul, South Korea, which connects real estate agents with renters. Founded in 2010, the company operates a real estate marketplace that facilitates apartment hunting through its mobile and web platforms. Users can search for rental properties based on various criteria, including the number of rooms, occupants, and price. ZigBang has reported a user base of approximately 6 million, providing a comprehensive tool for individuals seeking rental accommodations while aiming to optimize their search and potentially reduce housing costs.

Together Funding

Series B in 2019
Together Funding is a company that provides a peer-to-peer financial service platform aimed at connecting lenders, investors, and borrowers. The platform specializes in real estate collateral, facilitating online interactions where investors and borrowers can engage in transactions. Together Funding enables users to apply for loans and invest in financial products, offering a convenient online environment to help individuals achieve their financial goals. Through its innovative approach, the company streamlines the lending and investment processes, making it easier for users to navigate the financial landscape.

APR Corporation

Series B in 2018
APR Co., Ltd is a South Korean company established in 2014, specializing in the manufacture and sale of cosmetic products for both men and women. The company offers a diverse range of products, including medical cosmetics, diet products, and beauty devices. In addition to its core beauty offerings, APR operates an instant photo booth service and sells apparel such as caps, sweatshirts, and track tops through its online store. The company markets its products under several brand names, including APRILSKIN, medicube, GLAMD, Forment, Photogray ORAZIN, and NERDY. With a strong presence in both the domestic and international markets, particularly for its 'MediCube' brand, APR has established itself as a reputable player in the beauty and skincare industry.

Beatrain

Post in 2018
Beatrain is a developer and publisher of mobile games, specializing in casual social gaming. The company focuses on creating engaging experiences for players through a diverse portfolio that includes titles such as Cooking Puzzles, Soul Knights, Baba Penguin, Warrior Goes, Trinity Master, and Elysion Saga. By prioritizing user-friendly gameplay and social interaction, Beatrain aims to capture the interest of mobile gamers and deliver entertaining content across various platforms.

Perfect Corp.

Series A in 2017
Perfect Corp., established in 2014, specializes in developing augmented reality (AR) and artificial intelligence (AI) driven solutions for the beauty and fashion industry. The company offers a SaaS platform, YouCam for Enterprise, which includes virtual makeup, AR skin diagnostic tools, AI product recommendations, and more, enabling e-commerce businesses and brands to enhance customer experiences. Additionally, Perfect Corp. provides mobile apps like YouCam Makeup and YouCam Perfect, allowing consumers to virtually try products, diagnose skin, and engage with a community. The company operates globally, with offices in New Taipei, Taiwan, and San Jose, California.

Gorilla Technology

Series B in 2009
Gorilla Technology Group, Inc. is a technology company based in Taipei, Taiwan, specializing in video analytics, IoT security, and big data solutions. Founded in 2001, the company focuses on delivering business intelligence insights that enhance performance in sales, operations, and customer understanding. Its AI-driven platforms utilize machine learning and deep learning algorithms to identify and analyze digital content, enabling clients across various sectors, including healthcare, transportation, manufacturing, and retail, to make informed business decisions. Gorilla Technology's offerings also encompass network security and operational technology security solutions, addressing the diverse needs of commercial, industrial, municipal, and governmental clients. Notable clients include Shanghai Media Group, highlighting the company's capability to serve significant organizations.

Bionoxx

Bionoxx is a biotechnology company based in Seongnam-si, South Korea, focused on developing innovative cancer immunotherapy treatments. The company specializes in oncolytic virus therapies, particularly utilizing vaccinia viruses armed with transgenes to enhance safety and efficacy. Bionoxx's portfolio includes OTS-412 and mOTS-412, which are oncolytic viruses designed for cancer treatment. Additionally, the company develops universal tumor targeting antigen (UTTA) technologies, such as UTTA CAR-T and UTTA BsAb, aimed at eradicating solid tumors. Bionoxx also explores combination therapies like mOTS-412+ ICI to enhance immune responses against cancer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.